This summer I'm living in Japan, uniquely positioning me to observe some of the key metrics for ESGs through a global lens. This article will be part one of a multi part series covering ESG funds … [Read more...] about Global ESG Portfolios: Part 1
Background Today one of our top picks for 2019 "ADMA" saw significant downside after news of Purcell Julie & Leftowitz LLP intention to investigate ADMA for "potential breaches of fiduciary … [Read more...] about Are Law Firms Unfairly Targeting Biotech?
Tech Giant Slack is set to IPO through a direct listing this month. It will be trading under the symbol "SK" and marks the continuation of multi billion dollar valued tech giants going public with … [Read more...] about Slack Direct Listing, Gold Mine Or Money Pit?
Background We recently covered Uber and some of the headwinds they are facing. Since this research was released, few to none of the headwinds have been adequately addressed and the share price has … [Read more...] about UBER Update
Recently tech companies have been eager to go public and unload shares from the insiders to the less knowledgeable retail. Some have been successful, some have not. Zoom has seen success in their IPO … [Read more...] about Will Uber Make You Money In The Stock Market?
In this article I will discuss the following Zooms valuation & Finances; is 19 billion fair? Competitive landscapeRisks to investorsOther current opportunities for … [Read more...] about Is Zoom Really Worth $19 Billion?
Zoom has announced that it will be going public on April 18th 2019. This has generated substantial hype and lead to a valuation of $36 per share tomorrow. In this article I will discuss; Potential … [Read more...] about Should You Buy The ZOOM IPO?
Background Investors have recently been faced with many headwinds in the first half of 2019. With potential threats to Bulls positions constantly surfacing, 2019 has been volatile to say the least. … [Read more...] about Why I’m Bullish With Brexit
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Overview Trevena Inc. (Nasdaq: TRVN) is set to present tomorrow February 12 at 9:15 EST at the 21st Annual BIO CEO & … [Read more...] about TRVN to Present at BIO & CEO Conference
Introduction Trevena Inc. (Nasdaq: TRVN) spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA Type A meeting minutes. In a … [Read more...] about 2019 Should Be A Good Year For TRVN, But What’s Next?